The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Cholesterol and prostate cancer
Abstract
Cholesterol is a neutral lipid that accumulates in liquid‐ordered, detergent‐resistant membrane domains called lipid rafts. Lipid rafts serve as membrane platforms for signal transduction mechanisms that mediate cell growth, survival, and a variety of other processes relevant to cancer. A number of studies, going back many years, demonstrate that cholesterol accumulates in solid tumors and that cholesterol homeostasis breaks down in the prostate with aging and with the transition to the malignant state. This review summarizes the established links between cholesterol and prostate cancer (PCa), with a focus on how accumulation of cholesterol within the lipid raft component of the plasma membrane may stimulate signaling pathways that promote progression to hormone refractory disease. We propose that increases in cholesterol in prostate tumor cell membranes, resulting from increases in circulating levels or from dysregulation of endogenous synthesis, results in the coalescence of raft domains. This would have the effect of sequestering positive regulators of oncogenic signaling within rafts, while maintaining negative regulators in the liquid‐disordered membrane fraction. This approach toward examining the function of lipid rafts in prostate cancer cells may provide insight into the role of circulating cholesterol in malignant growth and on the potential relationship between diet and aggressive disease. Large‐scale characterization of proteins that localize to cholesterol‐rich domains may help unveil signaling networks and pathways that will lead to identification of new biomarkers for disease progression and potentially to novel targets for therapeutic intervention. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Sun, M., Yang, L., Feldman, R. I., Sun, X.-M., Bhalla, K. N., Jove, R., Nicosia, S. V., & Cheng, J. Q. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306295200 · Cited by 171
RetractedLipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Caveolin, a protein component of caveolae membrane coats
Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., & Anderson, R. G. W. (1992) · Cell · doi:10.1016/0092-8674(92)90143-z · Cited by 2,258
Partitioning of Lipid-Modified Monomeric GFPs into Membrane Microdomains of Live Cells
Zacharias, D. A., Violin, J. D., Newton, A. C., & Tsien, R. Y. (2002) · Science · doi:10.1126/science.1068539 · Cited by 2,235
Lipid sorting in epithelial cells
Simons, K., & Van Meer, G. (1988) · Biochemistry · doi:10.1021/bi00417a001 · Cited by 1,371
Simons, K., & Ikonen, E. (2000) · Science · doi:10.1126/science.290.5497.1721 · Cited by 1,275
Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities
Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105408200 · Cited by 1,158
Lipid rafts: bringing order to chaos
Pike, L. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200021-jlr200 · Cited by 1,138
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County
Shimizu, H., Ross, R., Bernstein, L., Yatani, R., Henderson, B., & Mack, T. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.210 · Cited by 890
Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors
Foster, L. J., de Hoog, C. L., & Mann, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0631608100 · Cited by 834
GPI-Anchored Cell-Surface Molecules Complexed to Protein Tyrosine Kinases
Štefanová, I., Hořejši, V., Ansotegui, I. J., Knapp, W., & Stockinger, H. (1991) · Science · doi:10.1126/science.1719635 · Cited by 826
Li, S., Couet, J., & Lisanti, M. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29182 · Cited by 777
Wary, K. K., Mariotti, A., Zurzolo, C., & Giancotti, F. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81604-9 · Cited by 718
Interaction of a Receptor Tyrosine Kinase, EGF-R, with Caveolins
Couet, J., Sargiacomo, M., & Lisanti, M. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30429 · Cited by 664
McMenamin, M. E., Soung, P., Perera, S., Kaplan, I. D., Loda, M. F., & Sellers, W. R. (1999) · PubMed · Cited by 640
Razani, B., Zhang, X. L., Bitzer, M., von Gersdorff, G., Böttinger, E. P., & Lisanti, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008340200 · Cited by 639
The statins as anticancer agents.
Chan, K., Oza, A. M., & Siu, L. L. (2003) · PubMed · Cited by 618
Boonyaratanakornkit, V., Scott, M. P., Ribon, V., Sherman, L., Anderson, S. M., Maller, J. L., Miller, W. T., & Edwards, D. P. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00304-5 · Cited by 589
Emerging Themes in Lipid Rafts and Caveolae
Galbiati, F., Razani, B., & Lisanti, M. P. (2001) · Cell · doi:10.1016/s0092-8674(01)00472-x · Cited by 567
Polarized sorting in epithelia
Simons, K., & Wandinger-Ness, A. (1990) · Cell · doi:10.1016/0092-8674(90)90357-k · Cited by 540
Mora, L. B., Buettner, R., Seigne, J. D., Diaz, J. I., Ahmad, N., Garcia, R., Bowman, T. L., Falcone, R., Fairclough, R., Cantor, A. B., et al. (2002) · PubMed · Cited by 533
Galbiati, F., Engelman, J. A., Volonte, D., Zhang, X. L., Minetti, C., Li, M., Hou, H., Kneitz, B., Edelmann, W., & Lisanti, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100828200 · Cited by 467
Lipid-dependent Targeting of G Proteins into Rafts
Moffett, S., Brown, D. A., & Linder, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.2191 · Cited by 429
Unravelling the activation mechanisms of protein kinase B/Akt
Scheid, M. P., & Woodgett, J. R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00562-3 · Cited by 390
Pike, L. J., & Miller, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22298 · Cited by 374
Neuroendocrine differentiation in prostatic carcinoma
Abrahamsson, P.-A. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990501)39:2<135::aid-pros9>3.0.co;2-s · Cited by 370
Serum interleukin 6 as a prognostic factor in patients with prostate cancer.
Nakashima, J., Tachibana, M., Horiguchi, Y., Oya, M., Ohigashi, T., Asakura, H., & Murai, M. (2000) · PubMed · Cited by 351
EphrinB Ligands Recruit GRIP Family PDZ Adaptor Proteins into Raft Membrane Microdomains
Brückner, K., Labrador, J. P., Scheiffele, P., Herb, A., Seeburg, P. H., & Klein, R. (1999) · Neuron · doi:10.1016/s0896-6273(00)80706-0 · Cited by 342
Parpal, S., Karlsson, M., Thorn, H., & Strålfors, P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007454200 · Cited by 340
Chun, M., Liyanage, U. K., Lisanti, M. P., & Lodish, H. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11728 · Cited by 334
Elevated expression of caveolin is associated with prostate and breast cancer.
Yang, G., Truong, L. D., Timme, T. L., Ren, C., Wheeler, T. M., Park, S. H., Nasu, Y., Bangma, C. H., Kattan, M. W., Scardino, P. T., et al. (1998) · PubMed · Cited by 331
Rietveld, A., Neutz, S., Simons, K., & Eaton, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12049 · Cited by 329
Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.
Zhuang, L., Lin, J., Lu, M. L., Solomon, K. R., & Freeman, M. R. (2002) · PubMed · Cited by 327
Self-citationBlais, L., Desgagné, A., & LeLorier, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2363 · Cited by 326
Antigen-induced translocation of PKC-θ to membrane rafts is required for T cell activation
Bi, K., Tanaka, Y., Coudronniere, N., Sugie, K., Hong, S., van Stipdonk, M. J. B., & Altman, A. (2001) · Nature Immunology · doi:10.1038/88765 · Cited by 306
Plasma cholesterol concentration and mortality. The Whitehall Study
Smith, G. D. (1992) · JAMA · doi:10.1001/jama.267.1.70 · Cited by 306
T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/Leu-4.
Gunter, K. C., Malek, T. R., & Shevach, E. M. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.3.716 · Cited by 297
Caveolae: anchored, multifunctional platforms in the lipid ocean
Deurs, B. V., Roepstorff, K., Hommelgaard, A. M., & Sandvig, K. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)00039-9 · Cited by 296
Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.
Yang, G., Truong, L. D., Wheeler, T. M., & Thompson, T. C. (1999) · PubMed · Cited by 283
Shenoy-Scaria, A. M., Kwong, J. M. K., Fujita, T., Olszowy, M. W., Shaw, A. S., & Lublin, D. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3535 · Cited by 276
Park, H.-J., Kong, D., Iruela-Arispe, L., Begley, U., Tang, D., & Galper, J. B. (2002) · Circulation Research · doi:10.1161/01.res.0000028149.15986.4c · Cited by 276
Wiechen, K., Diatchenko, L., Agoulnik, A., Scharff, K. M., Schober, H., Arlt, K., Zhumabayeva, B., Siebert, P. D., Dietel, M., Schäfer, R., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63010-6 · Cited by 275
Pedersen, T. R., Wilhelmsen, L., Færgeman, O., Strandberg, T. E., Thorgeirsson, G., Troedsson, L., Kristianson, J., Berg, K., Cook, T. J., Haghfelt, T., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00910-3 · Cited by 274
Liu, J., Oh, P., Horner, T., Rogers, R. A., & Schnitzer, J. E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7211 · Cited by 271
ERβ Has Nongenomic Action in Caveolae
Chambliss, K. L., Yuhanna, I. S., Anderson, R. G. W., Mendelsohn, M. E., & Shaul, P. W. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.5.0827 · Cited by 263
Schnitzer, J. E., Oh, P., Jacobson, B. S., & Dvorak, A. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1759 · Cited by 252
Dietary Fat and Prostate Cancer: Current Status
Kolonel, L. N., Nomura, A. M. Y., & Cooney, R. V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.414 · Cited by 251
Lipid rafts and little caves: Compartmentalized signalling in membrane microdomains
Zajchowski, L. D., & Robbins, S. M. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02715.x · Cited by 246
COOK, L. S., GOLDOFT, M., SCHWARTZ, S. M., & WEISS, N. S. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)62086-x · Cited by 241
Caveolin-1 Interacts with Androgen Receptor
Lu, M. L., Schneider, M. C., Zheng, Y., Zhang, X., & Richie, J. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006598200 · Cited by 239
Lawrence, J. C., Saslowsky, D. E., Michael Edwardson, J., & Henderson, R. M. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74990-x · Cited by 224
Platelet-derived growth factor activates mitogen-activated protein kinase in isolated caveolae
Liu, P., Ying, Y.-S., & Anderson, R. G. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13666 · Cited by 221
A prospective study on intake of animal products and risk of prostate cancer
Michaud, D. S., Augustsson, K., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2001) · Cancer Causes & Control · doi:10.1023/a:1011256201044 · Cited by 217
Tahir, S. A., Yang, G., Ebara, S., Timme, T. L., Satoh, T., Li, L., Goltsov, A. A., Ittmann, M., Morrisett, J. D., & Thompson, T. C. (2001) · PubMed · Cited by 215
Hooper, N. M., & Turner, A. J. (1988) · Biochemical Journal · doi:10.1042/bj2500865 · Cited by 214
Vincent, L., Chen, W., Hong, L., Mirshahi, F., Mishal, Z., Mirshahi-Khorassani, T., Vannier, J.-P., Soria, J., & Soria, C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02337-7 · Cited by 201
Hooper, N. M., & Turner, A. J. (1987) · Biochemical Journal · doi:10.1042/bj2410625 · Cited by 189
Thomas, P. M., & Samelson, L. E. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49841-4 · Cited by 188
Deeble, P. D., Murphy, D. J., Parsons, S. J., & Cox, M. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8471-8482.2001 · Cited by 185
Paez, J., & Sellers, W. R. (2006) · Cancer Treatment and Research · doi:10.1007/0-306-48158-8_6 · Cited by 180
Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects
Fiorenza, A. M., Branchi, A., & Sommariva, D. (2000) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990070013 · Cited by 172
Hill, M. M., Feng, J., & Hemmings, B. A. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00973-9 · Cited by 172
Heemers, H. (2001) · Molecular Endocrinology · doi:10.1210/me.15.10.1817 · Cited by 172
Koga, T., Shimada, Y., Kuroda, M., Tsujita, Y., Hasegawa, K., & Yamazaki, M. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90139-o · Cited by 168
Saeki, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg293 · Cited by 162
Dietary fat, cholesterol and colorectal cancer in a prospective study
Järvinen, R., Knekt, P., Hakulinen, T., Rissanen, H., & Heliövaara, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1906 · Cited by 161
The roles of membrane microdomains (rafts) in T cell activation
Hořejší, V. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00001.x · Cited by 150
Alonso, D. F., Fariña, H. G., Skilton, G., Gabri, M. R., Lorenzo, M. S. D., & Gomez, D. E. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006058409974 · Cited by 146
Podar, K., Tai, Y., Cole, C. E., Hideshima, T., Sattler, M., Hamblin, A. D., Mitsiades, N., Schlossman, R. L., Davies, F. E., Morgan, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208636200 · Cited by 146
Bini, L., Pacini, S., Liberatori, S., Valensin, S., Pellegrini, M., Raggiaschi, R., PALLINI, V., & Baldari, C. T. (2003) · Biochemical Journal · doi:10.1042/bj20020503 · Cited by 144
Statin Use and the Risk of Breast and Prostate Cancer
Coogan, P. F., Rosenberg, L. A., Palmer, J. R., Strom, B. L., Zauber, A. G., & Shapiro, S. (2002) · Epidemiology · doi:10.1097/00001648-200205000-00005 · Cited by 137
Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells
Hughes‐Fulford, M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.5.701 · Cited by 136
Biochemical changes in tumor tissues of oral cancer patients
Kolanjiappan, K., Ramachandran, C. R., & Manoharan, S. (2003) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00421-6 · Cited by 130
Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin
Wong, W. W.-L., Tan, M. M., Xia, Z., Dimitroualakos, J., Minden, M. D., & Penn, L. Z. (2001) · PubMed · doi:10.5167/uzh-58181 · Cited by 129
The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells
van de Donk, N. W. C. J., Kamphuis, M., Lokhorst, H. M., & Bloem, A. C. (2002) · Leukemia · doi:10.1038/sj.leu.2402501 · Cited by 127
Wächtershäuser, A., Akoglu, B., & Stein, J. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.1061 · Cited by 123
Serum cholesterol and risk of cancer in a cohort of 39,000 men and women
Knekt, P., Reunanen, A., Aromaa, A., Heliövaara, M., Hakulinen, T., & Hakama, M. (1988) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(88)90056-x · Cited by 115
Hooper, N. M., & Turner, A. J. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)81152-9 · Cited by 113
Solomon, K. R., Rudd, C. E., & Finberg, R. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.6053 · Cited by 110
Self-citationDietary Fat and Risk of Chronic Disease
Weisburger, J. H. (1997) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(97)00725-6 · Cited by 105
Diet and risk of adult glioma in eastern Nebraska, United States
Chen, H., Ward, M. H., Tucker, K. L., Graubard, B. I., McComb, R. D., Potischman, N. A., Weisenburger, D. D., & Heineman, E. F. (2002) · Cancer Causes & Control · doi:10.1023/a:1019527225197 · Cited by 104
Kaplan, S., Novikov, L., & Modan, B. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009201 · Cited by 99
Uptake of a Cholesterol-Rich Emulsion by Breast Cancer
Graziani, S. R., Igreja, F., Hegg, R., Meneghetti, C., Brandizzi, L. I., Barboza, R., Amâncio, R. F., Pinotti, J. A., & Maranhão, R. C. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6654 · Cited by 98
Lipid rafts: cell surface platforms for T cell signaling
Magee, T., Pirinen, N. J., Adler, J., Pagakis, S. N., & Parmryd, I. (2002) · Biological Research · doi:10.4067/s0716-97602002000200003 · Cited by 95
PC12 Cells Have Caveolae That Contain TrkA
Peiró, S., Comella, J. X., Enrich, C., Martı́n-Zanca, D., & Rocamora, N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000487200 · Cited by 93
The Cholesterol Content of Normal and Enlarged Prostates
Swyer, G. I. M. (1942) · Cancer Research · Cited by 90
On the occurrence of crystals in tumours
White, C. P. (1909) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700130103 · Cited by 88
Moorjani, S., Dupont, A., Labrie, F., Lupien, P.-J., Gagné, C., Brun, D., GIGUÉRE, M., Bélanger, A., & Cusan, L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-2-314 · Cited by 88
Satoh, T., Yang, G., Egawa, S., Addai, J. B., Frolov, A., Kuwao, S., Timme, T. L., Baba, S., & Thompson, T. C. (2003) · Cancer · doi:10.1002/cncr.11198 · Cited by 81
ER Has Nongenomic Action in Caveolae
Chambliss, K. L. (2002) · Molecular Endocrinology · doi:10.1210/me.16.5.938 · Cited by 78
Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women
Veierød, M. B., Laake, P., & Thelle, D. S. (1997) · European Journal of Cancer Prevention · doi:10.1097/00008469-199712000-00009 · Cited by 77
Kim, J., Adam, R. M., Solomon, K. R., & Freeman, M. R. (2003) · Endocrinology · doi:10.1210/en.2003-0772 · Cited by 75
Self-citationNarisawa, T., Fukaura, Y., Terada, K., et al. (1994) · Carcinogenesis · doi:10.1093/carcin/15.9.2045 · Cited by 74
Dietary fat and risk of lung cancer in a pooled analysis of prospective studies.
Smith‐Warner, S. A., Ritz, J., Hunter, D. J., Albanes, D., Beeson, W. L., van den Brandt, P. A., Colditz, G. A., Folsom, A. R., Fraser, G. E., Freudenheim, J. L., et al. (2002) · PubMed · Cited by 71
Fariña, H. G., Bublik, D. R., Alonso, D. F., & Gomez, D. E. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1020355621043 · Cited by 67
Gale, K. E., Andersen, J. W., Tormey, D. C., Mansour, E. G., Davis, T. E., Horton, J., Wolter, J. M., Smith, T. J., & Cummings, F. J. (1994) · Cancer · doi:10.1002/1097-0142(19940115)73:2<253::aid-cncr2820730204>3.0.co;2-f · Cited by 67
Increased levels of cholesterol esters in glioma tissue and surrounding areas of human brain
NYGREN, H. (1997) · British Journal of Neurosurgery · doi:10.1080/02688699746276 · Cited by 62
Elevated uptake of low density lipoprotein by drug resistant human leukemic cell lines
Tatidis, L., Masquelier, M., & Vitols, S. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01018-3 · Cited by 61
Inhibition of cdk2 Activating Phosphorylation by Mevastatin
Ukomadu, C., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208658200 · Cited by 61
Diet and the Risk of Salivary Gland Cancer
Horn‐Ross, P. L., Morrow, M., & Ljung, B. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009248 · Cited by 59
Adam, R. M., Kim, J., Lin, J., Orsola, A., Zhuang, L., Rice, D. C., & Freeman, M. R. (2002) · Endocrinology · doi:10.1210/en.2002-220561 · Cited by 56
Self-citationWadsack, C., Hrzenjak, A., Hammer, A., Hirschmugl, B., Levak‐Frank, S., Desoyé, G., Sattler, W., & Malle, E. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03394.x · Cited by 48
Wu, Y. G., Zheng, W., Sellers, T. A., Kushi, L. H., Bostick, R. M., & Potter, J. D. (1994) · Cancer Causes & Control · doi:10.1007/bf01694752 · Cited by 46
Influence of dietary levels of fat, cholesterol, and calcium on colorectal cancer
Stéfani, E. D., Mendilaharsu, M., Deneo‐Pellegrini, H., & Ronco, Á. L. (1997) · Nutrition and Cancer · doi:10.1080/01635589709514606 · Cited by 46
Toxicity of amphotericin B and its methyl ester toward normal and tumor cell lines.
Fisher, P. B., Goldstein, N. I., BONNER, D. P., Mechlinski, W., Bryson, V., & Schaffner, C. P. (1975) · PubMed · Cited by 38
Bauer, B., Jenny, M., Fresser, F., Überall, F., & Baier, G. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00287-4 · Cited by 35
Jiang, F., Yang, L.-P., Cai, X., Cyriac, J., Shechter, I., & Wang, Z. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00086-3 · Cited by 28
What do the statin trials tell us?
Waters, D. D. (2009) · Clinical Cardiology · doi:10.1002/clc.4960241502 · Cited by 9
Cited by
Zhuang, L., Kim, J., Adam, R. M., Solomon, K. R., & Freeman, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200519935 · Cited by 567
Self-citationAnti‐cancer properties of anthraquinones from rhubarb
Huang, Q., Lu, G., Shen, H., Chung, M. C. M., & Ong, C. N. (2007) · Medicinal Research Reviews · doi:10.1002/med.20094 · Cited by 559
Li, Y. C., Park, M. J., Ye, S.-K., Kim, C.-W., & Kim, Y.-N. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050959 · Cited by 536
Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer
Titus, M. A., Schell, M. J., Lih, F. B., Tomer, K. B., & Mohler, J. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0525 · Cited by 488
Statin Drugs and Risk of Advanced Prostate Cancer
Platz, E. A., Leitzmann, M. F., Visvanathan, K., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj499 · Cited by 406
Metadata
- Authors
- Freeman, M. R., & Solomon, K. R.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2003-10-27
- Volume
- 91
- Issue
- 1
- Pages
- 54-69
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W1997156303
- Cited by
- 266
- References
- 109
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.